Witnessing the stock’s movement on the chart, on March 02, 2021, 9 Meters Biopharma Inc. (NASDAQ: NMTR) had a quiet start as it plunged -6.32% to $1.63. During the day, the stock rose to $1.75 and sunk to $1.61 before settling in for the price of $1.74 at the close. Taking a more long-term approach, NMTR posted a 52-week range of $0.37-$2.26.
Meanwhile, its Annual Earning per share during the time was 43.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.80%. This publicly-traded company’s shares outstanding now amounts to $141.63 million, simultaneously with a float of $116.68 million. The organization now has a market capitalization sitting at $331.30 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4113, while the 200-day Moving Average is $0.8620.
9 Meters Biopharma Inc. (NMTR) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. 9 Meters Biopharma Inc.’s current insider ownership accounts for 0.90%, in contrast to 31.20% institutional ownership. According to the most recent insider trade that took place on Dec 15, this organization’s Director bought 230,769 shares at the rate of 0.65, making the entire transaction reach 150,000 in total value, affecting insider ownership by 774,066. Preceding that transaction, on Dec 15, Company’s Chief Executive Officer bought 153,846 for 0.65, making the whole transaction’s value amount to 100,000. This particular insider is now the holder of 977,522 in total.
9 Meters Biopharma Inc. (NMTR) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.06 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.06) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
9 Meters Biopharma Inc.’s EPS increase for this current 12-month fiscal period is 16.80% and is forecasted to reach -0.11 in the upcoming year.
9 Meters Biopharma Inc. (NASDAQ: NMTR) Trading Performance Indicators
Let’s observe the current performance indicators for 9 Meters Biopharma Inc. (NMTR). It’s Quick Ratio in the last reported quarter now stands at 1.30. The Stock has managed to achieve an average true range (ATR) of 0.20.
In the same vein, NMTR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.96, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.11 at the market close of one year from today.
Technical Analysis of 9 Meters Biopharma Inc. (NMTR)
Going through the that latest performance of [9 Meters Biopharma Inc., NMTR]. Its last 5-days volume of 4.14 million was inferior to the volume of 13.64 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 24.63% While, its Average True Range was 0.1990.
Raw Stochastic average of 9 Meters Biopharma Inc. (NMTR) in the period of the previous 100 days is set at 61.35%, which indicates a major rise in contrast to 14.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 95.28% that was lower than 117.81% volatility it exhibited in the past 100-days period.